|
SEC22B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.21218615542784E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.8276051479188E-11 |
| Normal-vs-Stage2 |
4.3970999999976E-06 |
| Normal-vs-Stage3 |
1.31490041077598E-10 |
| Normal-vs-Stage4 |
2.70599997964638E-09 |
| Stage1-vs-Stage2 |
9.984600E-01 |
| Stage1-vs-Stage3 |
2.222000E-01 |
| Stage1-vs-Stage4 |
2.465800E-01 |
| Stage2-vs-Stage3 |
4.433200E-01 |
| Stage2-vs-Stage4 |
4.038200E-01 |
| Stage3-vs-Stage4 |
8.451400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16493489801906E-14 |
| Normal-vs-AfricanAmerican |
6.079700E-03 |
| Normal-vs-Asian |
1.24919999999751E-06 |
| Caucasian-vs-AfricanAmerican |
3.014000E-02 |
| Caucasian-vs-Asian |
3.325400E-01 |
| AfricanAmerican-vs-Asian |
2.461000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.53720378040612E-11 |
| Normal-vs-Female |
4.28099777849411E-11 |
| Male-vs-Female |
2.607800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.70620004183542E-09 |
| Normal-vs-Age(41-60Yrs) |
4.70330441260103E-11 |
| Normal-vs-Age(61-80Yrs) |
1.32779998107679E-09 |
| Normal-vs-Age(81-100Yrs) |
7.197600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.439200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.018000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.934000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.736200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.003800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.054600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.355400E-01 |
| Classical-VS-Follicular |
9.357600E-01 |
| Classical-VS-Other |
2.340600E-01 |
| Classical-VS-Normal |
9.87920856232449E-12 |
| Tall-VS-Follicular |
8.115800E-01 |
| Tall-VS-Other |
2.626600E-01 |
| Tall-VS-Normal |
2.69669999997113E-06 |
| Follicular-VS-Other |
3.613000E-01 |
| Follicular-VS-Normal |
1.78870000000497E-06 |
| Other-VS-Normal |
3.237800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14130047027083E-10 |
| Normal-vs-N1 |
2.11259998383895E-09 |
| N0-vs-N1 |
4.016800E-01 |
|
|
